Edwin Lee
      Lawyers
    
     
Filters
Beijing Hongkun consent solicitations
        We advised Beijing Hongkun on the transaction
      
      Pop Mart HK$5.2 billion IPO and Hong Kong listing
        Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance…
      
      Zai Lab HK$5.94 billion secondary listing and IPO on the HKEX
        Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…
      
      ENN Energy $750 million senior notes offering
        Davis Polk advised the joint global coordinators and representatives of additional underwriters in connection with the Rule 144A/Regulation S offering by ENN Energy Holdings Limited of…
      
      Venus Medtech (Hangzhou) HK$1.2 billion H shares placement
        Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its placing of 18,500,000 new H shares for an aggregate consideration of approximately HK$1.2 billion (approximately US…
      
      Akeso HK$2.44 billion IPO
        Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…
      
      Tianfeng Securities $100 million notes offering
        Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…
      
      Zai Lab $300 million follow-on offering of ADSs
        Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
      
      Davis Polk Advises Venus Medtech (Hangzhou) Inc. on Its HK$2.59 Billion (US$331.17 Million) Initial Public Offering
        Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…
      
      Davis Polk Advised China International Capital Corporation Limited on Its Placing of New H Shares
        Davis Polk advised China International Capital Corporation Limited in connection with its placing of 176,000,000 new H shares at a total consideration of approximately HK$2.5 billion …